A randomized double-blind study of low-molecular-weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum) - Cosmi, B; Filippini, M; Tonti, D; STEFLUX Investigators (J Thromb Haemost, 2012)